Evidence map›Paper›PMID 37098036›Full record

ArticlePloS one2023

Feature selection for high dimensional microarray gene expression data via weighted signal to noise ratio.

Muhammad Hamraz, Amjad Ali, Wali Khan Mashwani, Saeed Aldahmani, Zardad Khan

Abstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Muhammad HamrazDepartment of Statistics, Abdul Wali Khan University Mardan, Mardan, Pakistan.
Amjad AliDepartment of Statistics, Abdul Wali Khan University Mardan, Mardan, Pakistan.
Wali Khan MashwaniInstitute of Numerical Sciences, Kohat University of Science and Technology, Kohat, Pakistan.ORCID 0000-0002-5081-741X
Saeed AldahmaniDepartment of Analytics in the Digital Era, United Arab Emirates University, Al Ain, UAE.
Zardad KhanDepartment of Analytics in the Digital Era, United Arab Emirates University, Al Ain, UAE.ORCID 0000-0003-3933-9143

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Feature selection in high dimensional gene expression datasets not only reduces the dimension of the data, but also the execution time and computational cost of the underlying classifier. The current study introduces a novel feature selection method called weighted signal to noise ratio (WSNR) by exploiting the weights of features based on support vectors and signal to noise ratio, with an objective to identify the most informative genes in high dimensional classification problems. The combination of two state-of-the-art procedures enables the extration of the most informative genes. The corresponding weights of these procedures are then multiplied and arranged in decreasing order. Larger weight of a feature indicates its discriminatory power in classifying the tissue samples to their true classes. The current method is validated on eight gene expression datasets. Moreover, results of the proposed method (WSNR) are also compared with four well known feature selection methods. We found that the (WSNR) outperform the other competing methods on 6 out of 8 datasets. Box-plots and Bar-plots of the results of the proposed method and all the other methods are also constructed. The proposed method is further assessed on simulated data. Simulation analysis reveal that (WSNR) outperforms all the other methods included in the study.

Indexed as

AlgorithmsGene Expression ProfilingGene ExpressionMicroarray AnalysisSignal-To-Noise Ratio

Identifiers

PMID37098036
PMCPMC10128961

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.